Global Nasal Cannula Market to reach USD XX billion by 2027.
Global Nasal Cannula Market is valued approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 8% over the forecast period 2021-2027. The nasal cannula is a device used to carry supplemental oxygen or increased airflow to a patient in need of respiratory assistance. They may be used in a variety of ways - hospital settings, at home, or on-the-go. The rising geriatric population worldwide, coupled with the increasing incidences of respiratory problems, are driving the Nasal Cannula market. The governmental support for the eradication of respiratory illness is helping the nasal cannula market to propel. According to World Health Organization, the number of people aged 65 or above is expected to touch nearly 1.5 billion in 2050 from 524 million in 2010, with developing countries registering the most of the increase in numbers. The number of older people in developing countries is expected to increase by more than 250 percent, in contrast with a 71 percent increase in developed countries between the period 2010 and 2050. The rising geriatric population highlights the need for nasal cannula to treat the respiratory problems. The chronic respiratory illness is also increasing. WHO also reports that Asthma affected an estimated 262 million people in 2019 and caused 461000 deaths. The lack of awareness about the use of nasal cannula may act as a restraint for its growth. However, increasing efforts from scientists and researchers for the technological advancements in the cure of respiratory illness acts as an opportunity for Nasal Cannula Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of Nasal Cannula Market. Due to increasing adoption of nasal cannula as well as higher per capita income, North America has emerged as a significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit the highest growth rate for the forecast period 2021-2027 owing to the growing population with chronic respiratory diseases. Rising disposable income and growing awareness for nasal cannula will also boost growth in this region.

Major market player included in this report are:
Allied Healthcare Products, Inc.
Besmed Health Business Corp.
Drive Devilbiss International
Fairmont Medical
Fisher And Paykel Healthcare Limited
Flexicare Medical Ltd
Resmed Inc.
Salter Labs
Sunset Healthcare Solutions Inc
Teleflex Incorporated

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Low Flow Nasal Cannula
High Flow Nasal Cannula

By Material:
Plastic
Silicone

By End Use:
Hospitals
Ambulatory Healthcare Services
Long Term Care Centers
Others

By Region:
North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027

Target Audience of the Global Nasal Cannula Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors